Globeimmune
GBIM · OTC
$0.0001+$0.00 (+0.00%)TodayMarket closed ·
No price history for this range.
Key indicators
GBIM profitability and balance sheet ratios
EPS -$0.1499 in Mar 2016, against -$0.2713 a year earlier.
| Period | EPS |
|---|---|
| Jun 2014 | -$1.11 |
| Sep 2014 | -$1.13 |
| Dec 2014 | -$0.301 |
| Mar 2015 | -$0.2713 |
| Jun 2015 | -$0.2269 |
| Sep 2015 | $0.1286 |
| Dec 2015 | -$0.1382 |
| Mar 2016 | -$0.1499 |
Income statement
No financial statements are reported for Globeimmune.
Balance sheet
What the company owns and owes at period end
Total assets
Total liabilities
| Line item | Sep 2015 | Dec 2015 | Mar 2016 |
|---|---|---|---|
| Total assets | $13.2M | $11.5M | $9.8M |
| Total liabilities | $9.5M | $8.5M | $7.6M |
| Shareholder equity | $3.8M | $3.0M | $2.2M |
| Cash and short-term investments | $11.3M | $9.9M | $8.7M |
| Total debt | $0.0M | $0.0M | $0.0M |
Information on this page is provided for informational purposes only and is not a recommendation to buy, sell or hold any security. Investing involves risk, including possible loss of principal. Market data is delayed at least 15 minutes and is provided without warranty. Analyst ratings, price targets and company data come from third-party sources. Past performance does not guarantee future results.